Patient response with lupus erythematosus to treatment with Yamamoto New Scalp Acupuncture (YNSA)

Abstract

It is estimated that 5 million people worldwide have some form of Lupus. It is an autoimmune, idiopathic and until now incurable disease, which affects, especially women in reproductive period. In the West, its treatment is educational, essentially medication, with administration of anti-inflammatories, antimalarials and immunosuppressants. For Traditional Chinese Medicine (TCM), Lupus is above all a syndromic imbalance, which varies according to its manifestation. The set of these disorders is classified as deterioration of the Spleen (Pi) and Heart (Xin), weakening of the Fire and the Door of Life. Treatment by MTC occurs with the administration of herbal medicines, diet therapies, acupuncture, massage, moxibustion, Qi Gong, magnetotherapy, wind therapy, flowers and others. YNSA (Yamamoto Neue Schädelakupunktur) is a somatotopic scalp therapy that, among other advantages, has access points to the 12 main meridians, bilaterally. Usually used in case of pain, neurological disorders and surgical conditions, it has its own diagnostic methods that also serve to monitor the treatment. Ryodoraku is the most sensitive and reproducible current diagnostic tool for identifying the average circulating energy in the meridians. This research aimed to identify the usefulness of YNSA in the treatment of lupus patients. In this process, the energy evolution of a patient with lupus considered severe was monitored, over 23 applications of YNSA. It was compared with the results of acupuncture with those of allopathy. With YNSA, in addition to relaxation and pain control, there was greater energy adequacy. The relevant gains over the 23 applications of YNSA, reaching three times the initial energy pattern, have almost completely retreated to exclusive treatment with allopathy. In effect, chloroquine diphosphate brought much more losses than gains.